Abstract: Apparatus and techniques for an integrated circuit (IC) package to automatically detect, through an input/out pin, external component parameters and parasitics. An example IC package generally includes a pin for coupling to a component external to the IC package, and at least one of a resistance detector, an inductance detector, or a capacitance detector coupled to the pin, and configured to detect at least one of a resistance, an inductance, or a capacitance, respectively, of a lumped parameter model for the component external to the IC package. The resistance detector, inductance detector, or capacitance detector may also be configured to detect parasitics associated with at least one of the component, the pin, or a connection between the component and the pin.

Abstract: Apparatus and techniques for an integrated circuit (IC) package to automatically detect, through an input/out pin, external component parameters and parasitics. An example IC package generally includes a pin for coupling to a component external to the IC package, and at least one of a resistance detector, an inductance detector, or a capacitance detector coupled to the pin, and configured to detect at least one of a resistance, an inductance, or a capacitance, respectively, of a lumped parameter model for the component external to the IC package. The resistance detector, inductance detector, or capacitance detector may also be configured to detect parasitics associated with at least one of the component, the pin, or a connection between the component and the pin.

Abstract: The present disclosure discloses a Fiber Reinforced Polymer/Plastic (FRP) composite spiral stirrup confined concrete column and a compression design method. The FRP composite spiral stirrup includes an internal FRP spiral stirrup and an external FRP square stirrup. In the form of the FRP composite spiral stirrup, effective transverse stress transfer is established by effectively binding stirrups, which can give full play to the mechanical properties of the FRP bars, provide “dual confinement” for core concrete, and greatly improve the peak stress of the core concrete. Confining mechanisms of the FRP composite spiral stirrup to the concrete in different areas are analyzed, a confinement model and a bearing capacity calculation method for the FRP composite spiral stirrup confined concrete column are proposed, and a design method for the FRP composite spiral stirrup confined concrete column is proposed after an accurate calculation method for the bearing capacity is obtained.

Abstract: The present invention includes a device and a method of using the device, wherein the device is a microfluidic device for single or multicell capture comprising: a substrate; one or more microgrooves or microtubes disposed within the substrate, each N microgroove or microtube having a first end and a second end, wherein a width of the microgroove or microtube is a diameter of a target cell or a group of cells, wherein the microgroove or microtube comprises one or more chambers; a fluid input disposed within the substrate in fluid communication with the first end of the one or more microgrooves or microtube; and a fluid output disposed within the substrate in fluid communication with the second end of the one or more microgrooves or microtube, or the one or more chambers, wherein one or more cells that are captured in the microgroove can be analyzed as a single cell.

Abstract: A simultaneous low quiescent current and high performance low dropout (LDO) voltage regulator is disclosed. In some implementations, the LDO voltage regulator includes a first and a second pass transistors configured to receive an input voltage (Vin). The LDO voltage regulator further includes an error amplifying module having a first output, a second output, a first input, and a second input. The error amplifying module can further include a first output stage configured to drive the gate of the first pass transistor during a high performance (HP) mode, and a second output stage configured to drive the gate of the second pass transistor during the HP mode and during a low power (LP) mode.

Abstract: A low-dropout (LDO) regulator and an associated method and apparatus are described. The LDO regulator generally includes a first transistor coupled between an input voltage node and an output voltage node of the LDO regulator. The LDO regulator further includes a first amplifier having an output coupled to a gate of the first transistor, wherein a feedback path couples the output voltage node to an input of the first amplifier. The LDO regulator further includes a second amplifier having an output coupled to an enable input of the first amplifier, wherein a voltage-sensing path couples the input voltage node to an input of the second amplifier. The LDO regulator further includes and a second transistor coupled between the gate of the first transistor and a reference potential node, the output of the second amplifier being coupled to a gate of the second transistor.

Abstract: A low-dropout (LDO) regulator and an associated method and apparatus are described. The LDO regulator generally includes a first transistor coupled between an input voltage node and an output voltage node of the LDO regulator. The LDO regulator further includes a first amplifier having an output coupled to a gate of the first transistor, wherein a feedback path couples the output voltage node to an input of the first amplifier. The LDO regulator further includes a second amplifier having an output coupled to an enable input of the first amplifier, wherein a voltage-sensing path couples the input voltage node to an input of the second amplifier. The LDO regulator further includes and a second transistor coupled between the gate of the first transistor and a reference potential node, the output of the second amplifier being coupled to a gate of the second transistor.

Abstract: A simultaneous low quiescent current and high performance low dropout (LDO) voltage regulator is disclosed. In some implementations, the LDO voltage regulator includes a first and a second pass transistors configured to receive an input voltage (Vin). The LDO voltage regulator further includes an error amplifying module having a first output, a second output, a first input, and a second input. The error amplifying module can further include a first output stage configured to drive the gate of the first pass transistor during a high performance (HP) mode, and a second output stage configured to drive the gate of the second pass transistor during the HP mode and during a low power (LP) mode.

Abstract: A compound of Formula I, wherein R1, R2, R3, R4, R5 and R6 are independently hydrogen, halogen, an unsubstituted alkyl, alkenyl, alkynyl, cydoalkyi, cydoalkylalkyi, aryl, phenyl, or naphthyl group, and a substituted alkyl, alkenyl, alkynyl, cydoalkyi, cydoalkylalkyi, aryl, phenyl, or naphthyl group having as a substituent a halogen, alkoxy, substituted phenoxy, unsubstituted phenoxy group or a heteroatom such as oxygen, sulfur, nitrogen, phosphorus and boron.

Abstract: A method for retarding an ethylene response in a plant or plant part comprising the step of contacting the plant or plant part with an ethylene response retarding amount of benzocyclopropene and/or naphtho[b]cyclopropane.

Abstract: In a workstation environment, several applications operate concurrently and it is desirable to communicate between applications. The present invention provides an apparatus for communicating between applications by using an extensible communication protocol with a graphical user interface. The user transmits an interest object associated with an event from a second application to a server, which forwards the interest object to a first application. When the first application practices the event, information concerning the practice of the event is transmitted from the first application to the second application without going through the server.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: A Distributed Framework Intertask Communication Method and Apparatus providing a method for communicating between applications using an extensible communication protocol with an intuitive user interface allowing the user to easily visualize and control the connectivity between applications. The user transmits an interest object associated with an event from a first application to a server. The server then retransmits that interest object to a second application. When the second application practices that event, information concerning the practice of that event is transmitted directly from the second application to the first application without routing that event information through the server.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

Abstract: Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.